 |
3-[2-(1-methylpyrrolidin-2-yl) ethyl]-6-(2-pyrrolidin-1yl) ethyl-9-benzyloxycarbonyl-12-diethyl-4,7-dioxo-3,6,9,12-tetraazadodecancarboxamide |
|---|---|
| Trade Name | |
| Orphan Indication | Anterior ischemic optic neuropathy |
| USA Market Approval | USA |
| USA Designation Date | 2017-12-26 00:00:00 |
| Sponsor | Neurizon Pharma;15 Paul-Ehrlich-Stra�e;T�bingen |
